Semin Respir Crit Care Med 1999; 20(5): 445-452
DOI: 10.1055/s-2007-1009464
Copyright © 1999 by Thieme Medical Publishers, Inc.

Chronic Thromboembolic Pulmonary Hypertension

Richard I. Whyte* , Ramona L. Doyle
  • *Division of Thoracic Surgery, Department of Cardiothoracic Surgery and
  • †Division of Pulmonary and Critical Care Medicine Stanford University, Stanford, California
Further Information

Publication History

Publication Date:
20 March 2008 (online)

Abstract

Pulmonary thromboendarterectomy (PTE) offers a highly effective form of treatment for patients with chronic thromboembolic pulmonary hypertension (CTEPH). Symptoms are due to progressive right-sided heart failure secondary to an obstructed pulmonary vascular tree. Patient evaluation includes nuclear scintigraphy, pulmonary angiography, and right heart catheterization and should differentiate patients with CTEPH from those with other forms of pulmonary hypertension. The operation typically requires bilateral thromboendarterectomy using cardiopulmonary bypass and periods of circulatory arrest. The chronic, organized thrombi that obstruct the major pulmonary vessels (main, lobar, and segmental) are removed, and there is immediate improvement in pulmonary hemodynamics. Mortality of PTE has been reported as low as 5% and the majority of patients experience significant long-term benefits in hemodynamics and symptoms.